LOEB & LOEB LLP
                                 345 Park Avenue
                             New York, NY 10154-0037

Direct Dial: 212-407-4827
Direct Fax:  212-214-0686
Email: dfischer@loeb.com

                                October 26, 2005

Max A. Webb,
Assistant Director
Division of Corporate Finance
Mail Stop -- 3561
Securities and Exchange Commission
Washington DC 20549-0402

                    Re:   AVP, Inc.
                          Amendment No. 5 to Registration Statement on Form SB-2
                          File No. 333-124084
                          Filed on or about October 26, 2005
                          ------------------------------------------------------

Dear Mr. Webb:

      Oral comments  received from the staff regarding the captioned  matter and
our responses are set forth below.

      1.  Include a Recent  Developments  section,  in which  you  state  that a
one-for-ten  reverse stock split has been  authorized  but not yet  implemented;
that any  increase in the price of AVP's stock may not be  proportionate  to the
reverse split; and that upon  effectuation of the reverse split, AVP will file a
post-effective  amendment  reflecting  changed share amounts  resulting from the
reverse split.

      We have included such a section  immediately  after the first paragraph of
the Prospectus Summary, on the first page of the prospectus.

      2. Refile the legal opinion, as indicated.

      The indication  was an error,  which we have corrected in the third column
of the  Exhibit  Index,  Exhibit  5.1.  Also,  as we advised  the staff,  we are
refiling Exhibit 3.1, to include an amendment authorized on August 23, 2005.

      3. Provide pro forma information in the financial statements and notes
giving retro-active effect to a one-for-ten reverse stock split authorized
August 23, 2005, but not yet effectuated. In addition, provide pro forma
information for the following schedules:

      1.    Securities authorized for issuance under equity compensation plans
            (page 10)

      2.    Equity compensation (page 11)

      3.    Outstanding equity securities (page 12)

In addition, provide, where shares are commented, whether or not a pro forma
effect is disclosed.

We have included such information in each appropriate section of the prospectus.


                                        Cordially,

                                        /s/ David C. Fischer

                                        David C. Fischer